Press Releases

Featured Press Releases

BIO Statement on National Security Commission on…

WASHINGTON, DC, April 8, 2025 – Today, the National Security Commission on Emerging Biotechnology (NSCEB), a bipartisan legislative commission established by Congress, issued its much-anticipated report detailing how the United States risks…

Learn more

BIO Statement on Resignation of Peter Marks from…

John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the FDA: “Under the extraordinary leadership of Dr. Peter Marks, the FDA…

Learn more

New survey: U.S. biotechs warn tariffs could…

WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical supply chain. According to the findings, nearly 90…

Learn more

BIO Welcomes U.S. Involvement in COVAX, ACT Accelerator Programs

January 21, 2021

The Biden administration just announced its intent for the United States to join the COVAX vaccine facility, which aims to deliver COVID-19 vaccines to poor and under-developed countries. Dr. Michelle McMurry-Heath, president and CEO of the…

BIO and LCFC Support New Mexico Governor's Vision to Address Climate Change Through Clean Fuel Standard

January 20, 2021

Washington, D.C. (January 20, 2021) — The BiotechnologyInnovation Organization (BIO) and the Low Carbon Fuels Coalition (LCFC) today released the following statement in support of New Mexico Governor Michelle Lujan Grisham’s inclusion of a…

BIO Condemns Trump Administration's Last-ditch Effort To Strip Critical Medicare Part D Protections

January 20, 2021

In his last day in office, former President Donald Trump proposed a sweeping change to Medicare’s “Part D” drug benefit. Billed as a demonstration project through the Centers for Medicare and Medicaid Innovation (CMMI), this new policy would allow…

BIO Congratulates President Biden and Vice President Harris on "Historic Inauguration"

January 20, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO) made the following remarks after President Joe Biden and Vice President Kamala Harris were sworn into office: “On behalf of the Biotechnology…

Biotechnology’s Leading Trade Group Restructures for the Future

January 19, 2021

Washington, DC – The Biotechnology Innovation Organization (BIO), which announced its transition to a new CEO in June to Dr. Michelle McMurry-Heath, is announcing a new leadership team and organizational structure that promises to provide long…

BIO Applauds Incoming Administration's Decision Elevating Key White House Science Post to Cabinet-level Agency

January 16, 2021

President-elect Joe Biden announced on Friday a plan to make the White House Office of Science and Technology Policy a Cabinet-level agency. Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), made the…

Trump Administration Move to Issue RFS Waivers "Beyond Egregious"

January 12, 2021

Stephanie Batchelor, vice president of BIO's Industrial and Environmental Section, released the following statement in reaction to the Trump administration's move to issue Renewable Fuel Standard (RFS) waivers for the 2019 compliance year. “This…

BIO Releases Statement Concerning Future Political Giving

January 11, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on BIO's political contributions: "As of today BIO will be pausing our political giving so we can…

BIO Statement on CMS' Approval of TennCare Medicaid Waiver

January 11, 2021

Dan Durham, Executive Vice President for Health Policy at the Biotechnology Innovation Organization, released the following statement regarding the recent decision by the Centers for Medicare and Medicaid Services (CMS) to approve the Tennessee…

BIO's Dr. Michelle McMurry-Heath Responds to "Unconscionable" Attacks on U.S. Capitol

January 6, 2021

Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization, made the following comments in response to today's violence at the United States Capitol: "Today we watched in horror as angry and unruly mobs attacked…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.